Real-time enrollment status for this neuroendocrine carcinoma clinical trial
Current Status
Recruiting
Checked: November 15, 2026 at 2:54 PM UTC
| NCT Number | NCT05058651 |
| Recruiting Status | Recruiting |
| Condition | Neuroendocrine Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 189 participants |
| Active Locations | 266 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | November 12, 2026 (3 days ago) |
As of November 15, 2026: Clinical trial NCT05058651 is currently recruiting participants. This phase2 study for neuroendocrine carcinoma is actively seeking new participants at 266 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05058651 is actively recruiting participants as of November 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 266 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05058651 was last updated 3 days ago (November 12, 2026). HelloStudys verifies this status automatically.